TANDEM
DEAD

Serial Number

98258202

Owner

BIOPHARM COMMUNICATIONS, LLC

Attorney

Jordan A. LaVine

Filing Date

Nov 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TANDEM Trademark

Serial Number: 98258202

TANDEM is a trademark filed by BIOPHARM COMMUNICATIONS, LLC on November 7, 2023. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BIOPHARM COMMUNICATIONS, LLC (39 trademarks)

290 Union Square Drive
New Hope, PA 18938

Entity Type: 16

Trademark Details

Filing Date

November 7, 2023

Registration Date

Not Registered

Goods & Services

Business marketing and promotional services in the field of healthcare; business consulting and marketing services in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; marketing consultation, namely, customer targeting consultancy services in the field of healthcare; advertising services, namely, promoting and marketing the goods and services of others in the healthcare field through all public communication means; advertising and marketing services provided by means of indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels in the field of healthcare; advertising and marketing services, namely, promoting the goods and services of others in the field of healthcare; analysis of market research data and statistics in the field of healthcare; business management consulting with relation to strategy, marketing, sales, operation, product design particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions in the field of healthcare; marketing services for others in the nature of using analytics to understanding and predict consumers, businesses, and market trends and actions; direct marketing services in the field of healthcare; collection of market research information in the field of healthcare; computerized market research services in the field of healthcare; direct marketing consulting services in the field of healthcare; market analysis and research services in the field of health care; market intelligence services in the field of healthcare; marketing analysis services in the field of healthcare; marketing and consulting services in the field of promoting and tracking the goods, services, and brands of others through all public communication means, particularly specializing in the use of mobile, social, and print media to drive consumer interest, engagement and action in the field of healthcare; providing demand creation and lead generation activities and services in the field of healthcare; providing advertising, marketing and promotional services for the healthcare, pharmaceutical and medical industries

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 7, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 7, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 13, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2023 NWOS
NEW APPLICATION ENTERED
Nov 10, 2023 NWAP